中文 | ENG

第58卷 第2期 2025-3
Predatory publisher and low standard journal: An emerging problem in clinical surgery field

.........................

第58卷 第2期 2025-3
Conflict of interest in clinical surgery: Contemporary concern in digital era

.........................

第58卷 第2期 2025-3
Postpublication redecision and pitfalls of inadequate standards in scientific surgical journals: Important consideration in academic publication

.........................

第58卷 第2期 2025-3
Spontaneous bilateral basal ganglia hemorrhage

.........................

第58卷 第2期 2025-3
Academic characterization of the Formosan Journal of Surgery: A five-year bibliometric analysis

.........................

第58卷 第2期 2025-3
Supra-sternal reconstruction for a high-hanging fruit like right subclavian artery aneurysm

.........................

第58卷 第2期 2025-3
Operations for choledochal cysts: A 25-year experience at a tertiary care center in India

.........................

第58卷 第2期 2025-3
A case report: Can a titanised polypropylene mesh (TiMesh) obviate a dual mesh for sandwich technique for parastomal hernias?

.........................

第58卷 第2期 2025-3
Recurrent gallstone ileus, a deadly encounter: A case report

.........................

第58卷 第2期 2025-3
The changes in dietary intake and tolerance for Chinese food after bariatric surgery in Taiwan

.........................

第58卷 第2期 2025-3
Diagnostic value of trans-recto-perineal ultrasound in perianal fistula—preoperative versus intraoperative findings: A comparative cross-section study

.........................

第58卷 第2期 2025-3
Efficacy and safety of extended-release dinalbuphine sebacate for postoperative analgesia: A systematic review and meta-analysis

.........................

第58卷 第2期 2025-3
Dynamic changes in segmented neutrophil-to-monocyte ratio in trauma patients with stress-induced hyperglycemia: A retrospective study

.........................

第58卷 第1期 2025-1
Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies

.........................

第58卷 第1期 2025-1
Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols

.........................

第58卷 第1期 2025-1
Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones

.........................

第58卷 第1期 2025-1
Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report

.........................

第58卷 第1期 2025-1
Pilonidal sinus of scrotum: A rare clinical entity

.........................

第58卷 第1期 2025-1
Incidental autopsy finding of retiform hemangioendothelioma of the spleen

.........................

第58卷 第1期 2025-1
Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series

.........................
登入帳號才能閱讀全文
 
篇名 Effect of 5-Fluorouracil on N-Acetyltransferase Activity in Colon Cancer Tissues
作者 Chi-Fu Hung, Jin-Gung Chung, Kau-Chi Ku, Jen-Liao
卷期/出版年月 32卷6期 (1999/12)
頁次 245-251
摘要 Human epidemiological studies suggest an association between N-acetyltransferase (NAT) and colon cancer. Arylamine N-acetylation capacity of the human colon mucosa, catalyzed by acetyl coenzyme A-dependent N-acetyltransferase, may be an important causative factor in the inititation of colorectal cancer. Human healthy colon mucosa and colon cancerous cytosol (subcellular fraction) from 40 fresh surgical samples were investigated for the effect of 5-fluorouracil (5-FU) on the activity of NAT toward p-aminiobenzoic acid and 2-amniofluorene using an acetyl coenzyme A (AcCoA) recycling assay and high pressure liquid chromatography (HPLC). 5-FU is a cancer chemotherapeutic agent used in the treatment of colon cancerous cytosol is found to be inhibited by 5-FU. Its presence in the assay medium shows an inhibition in PABA-NAT activity about of 23.4% and 50.5% in healthy colon mucosa (p<0.05), 48.3% and 73.8% in cancerous colon tissues (p<0.02) at 1mM and 2mM of 5-FU concentrations respectively; while as AF-NAT activity decreased about 21.2% and 55.1% in healthy colon mucosa (p<0.05), 42.2% and 68.4% in cancerous colon tissues (p<0.02) with 1mM and 2mM of 5-FU concentrations respectively. The results of this study show that NAT activity in colon cancerous tissue cytosol is higher than that in healthy colon mucosa cytosol, and 5-FU can inhibit NAT activity in healthy colon mucosa as well as in colon cancerous tissue cytosol which can be attributed to its anticancer activity of 5-FU.
關鍵詞 arylamin, colon cancer, 5-fluorouracil, N-acetyltransferase.
分類 Original Articles

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw